Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-53,900
Closed -$2.02M 42
2016
Q4
$2.02M Hold
53,900
1.03% 23
2016
Q3
$1.98M Buy
53,900
+30,500
+130% +$1.02M 1.15% 24
2016
Q2
$787K Buy
+23,400
New +$752K 0.47% 40
2015
Q2
Sell
-81,675
Closed -$4.08M 47
2015
Q1
$4.08M Sell
81,675
-34,350
-30% -$1.86M 1.46% 29
2014
Q4
$7.6M Hold
116,025
2.65% 17
2014
Q3
$8.83M Sell
116,025
-27,250
-19% -$2.25M 2.96% 15
2014
Q2
$11.8M Sell
143,275
-30,699
-18% -$2.29M 2.97% 14
2014
Q1
$12.2M Sell
173,974
-25,286
-13% -$1.73M 3.09% 14
2013
Q4
$14.3M Sell
199,260
-24,398
-11% -$1.77M 3.59% 7
2013
Q3
$15.8M Sell
223,658
-43,088
-16% -$2.88M 3.43% 7
2013
Q2
$16.6M Buy
+266,746
New +$16.4M 3.44% 9

Other funds holding NOV

Cambrian Capital's NOV Position: Q1 2017 in Review

Cambrian Capital sold out of NOV (NOV) in Q1 2017, closing a stake of 53,900 shares — an estimated $2.02M sold.

Cambrian Capital first reported a position in NOV in Q2 2013 and held it in 11 quarters. The position peaked at $16.6M in Q2 2013. 640 funds tracked by Wall St. Rank hold NOV as of Q1 2017.

  • Cambrian Capital reported no remaining NOV position as of Q1 2017 after selling out during the quarter.
  • Cambrian Capital sold 53,900 NOV shares in Q1 2017, an estimated $2.02M.
  • Cambrian Capital first reported a position in NOV in Q2 2013 and held it in 11 quarters.
  • Cambrian Capital's NOV position peaked at $16.6M in Q2 2013.
  • 640 funds tracked by Wall St. Rank held NOV as of Q1 2017.

Based on Cambrian Capital's 13F filing for Q1 2017, filed 15 May 2017.